Tag: global primary care poc diagnostics market

Uncover key drivers, emerging technologies, and competitive movements shaping the primary care poc diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Primary Care POC Diagnostics Market from 2026 to 2030?

The primary care poc diagnostics market size has experienced strong growth in recent years. This market is projected to expand from $17.38 billion in 2025 to $18.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be attributed to factors such as the rising prevalence of infectious and chronic diseases, broader adoption of glucose and cardiometabolic testing, the expansion of primary care diagnostic capabilities, increased use of over-the-counter diagnostic products, and improved accessibility of rapid tests.

The primary care poc diagnostics market is projected to experience substantial expansion in the coming years. It is anticipated to reach $24.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period can be primarily attributed to factors such as the increasing demand for decentralized diagnostic solutions, the rising incorporation of AI-enabled diagnostics, the broadening of telehealth-supported testing services, a heightened emphasis on preventive health screening, and increased investments in personalized diagnostic approaches. Key trends observed within this forecast period include the expanding adoption of rapid diagnostic testing, the growing integration of digital point-of-care devices, an escalating demand for at-home diagnostic kits, the expansion of multiplex testing platforms, and a strengthened focus on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

What Drivers Are Affecting Demand In The Primary Care POC Diagnostics Market?

The primary care POC diagnostics market is expected to see growth propelled by the increasing prevalence of infectious diseases. These conditions stem from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. They spread directly or indirectly between individuals through contact with contaminated surfaces, air, water, or vectors like insects. Contributing factors to their widespread nature include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics are crucial tools in diverse healthcare settings, combating these diseases by enabling early detection, timely treatment, and effective control measures. For instance, in March 2025, the Centers for Disease Control and Prevention (CDC), a US federal agency, reported that tuberculosis cases escalated from 9,622 in 2023 to 10,347 in 2024, an 8% increase, with the incidence rate also climbing from 2.9 to 3.0 per 100,000 population, a 6% rise. Hence, the rising prevalence of infectious diseases is a significant driver for the primary care POC diagnostics market.

Which Segments Are Gaining Traction In The Primary Care POC Diagnostics Market?

The primary care poc diagnostics market covered in this report is segmented –

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products

2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

Which Trends Are Guiding The Evolution Of The Primary Care POC Diagnostics Market?

Major companies operating in the primary care POC diagnostics market are focusing on developing advanced microfluidic-based rapid susceptibility testing to enhance timely antibiotic decision-making. Such microfluidic rapid susceptibility testing employs tiny fluid channels to swiftly isolate and cultivate bacteria, enabling early identification of their responsiveness to different antimicrobials and reducing the waiting period for results. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostic solutions company, launched the PA-100 AST System, which features proprietary microfluidic technology. This system can detect bacteria from urine samples in about 15 minutes and provide antimicrobial susceptibility test (AST) results in as little as 30 minutes at the initial clinic visit. The analyzer is compact, desktop-sized, and utilizes reagent cartridges into which samples are directly placed for automatic measurement. Healthcare professionals lacking specialized lab training can operate it easily. By accelerating diagnostics, the device supports appropriate antimicrobial use during first patient visits and assists in the global fight against antimicrobial resistance.

Who Are The Primary Competitors In The Global Primary Care POC Diagnostics Market?

Major companies operating in the primary care poc diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care poc diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Primary Care POC Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2026, By The Business Research Company

Poc Medical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/poc-medical-imaging-global-market-report

Point Of Care Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the primary care poc diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Primary Care POC Diagnostics Market from 2026 to 2030?

The primary care poc diagnostics market size has experienced strong growth in recent years. This market is projected to expand from $17.38 billion in 2025 to $18.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be attributed to factors such as the rising prevalence of infectious and chronic diseases, broader adoption of glucose and cardiometabolic testing, the expansion of primary care diagnostic capabilities, increased use of over-the-counter diagnostic products, and improved accessibility of rapid tests.

The primary care poc diagnostics market is projected to experience substantial expansion in the coming years. It is anticipated to reach $24.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period can be primarily attributed to factors such as the increasing demand for decentralized diagnostic solutions, the rising incorporation of AI-enabled diagnostics, the broadening of telehealth-supported testing services, a heightened emphasis on preventive health screening, and increased investments in personalized diagnostic approaches. Key trends observed within this forecast period include the expanding adoption of rapid diagnostic testing, the growing integration of digital point-of-care devices, an escalating demand for at-home diagnostic kits, the expansion of multiplex testing platforms, and a strengthened focus on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

What Drivers Are Affecting Demand In The Primary Care POC Diagnostics Market?

The primary care POC diagnostics market is expected to see growth propelled by the increasing prevalence of infectious diseases. These conditions stem from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. They spread directly or indirectly between individuals through contact with contaminated surfaces, air, water, or vectors like insects. Contributing factors to their widespread nature include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics are crucial tools in diverse healthcare settings, combating these diseases by enabling early detection, timely treatment, and effective control measures. For instance, in March 2025, the Centers for Disease Control and Prevention (CDC), a US federal agency, reported that tuberculosis cases escalated from 9,622 in 2023 to 10,347 in 2024, an 8% increase, with the incidence rate also climbing from 2.9 to 3.0 per 100,000 population, a 6% rise. Hence, the rising prevalence of infectious diseases is a significant driver for the primary care POC diagnostics market.

Which Segments Are Gaining Traction In The Primary Care POC Diagnostics Market?

The primary care poc diagnostics market covered in this report is segmented –

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products

2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

Which Trends Are Guiding The Evolution Of The Primary Care POC Diagnostics Market?

Major companies operating in the primary care POC diagnostics market are focusing on developing advanced microfluidic-based rapid susceptibility testing to enhance timely antibiotic decision-making. Such microfluidic rapid susceptibility testing employs tiny fluid channels to swiftly isolate and cultivate bacteria, enabling early identification of their responsiveness to different antimicrobials and reducing the waiting period for results. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostic solutions company, launched the PA-100 AST System, which features proprietary microfluidic technology. This system can detect bacteria from urine samples in about 15 minutes and provide antimicrobial susceptibility test (AST) results in as little as 30 minutes at the initial clinic visit. The analyzer is compact, desktop-sized, and utilizes reagent cartridges into which samples are directly placed for automatic measurement. Healthcare professionals lacking specialized lab training can operate it easily. By accelerating diagnostics, the device supports appropriate antimicrobial use during first patient visits and assists in the global fight against antimicrobial resistance.

Who Are The Primary Competitors In The Global Primary Care POC Diagnostics Market?

Major companies operating in the primary care poc diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care poc diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Primary Care POC Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2026, By The Business Research Company

Poc Medical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/poc-medical-imaging-global-market-report

Point Of Care Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the primary care poc diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Primary Care POC Diagnostics Market from 2026 to 2030?

The primary care poc diagnostics market size has experienced strong growth in recent years. This market is projected to expand from $17.38 billion in 2025 to $18.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be attributed to factors such as the rising prevalence of infectious and chronic diseases, broader adoption of glucose and cardiometabolic testing, the expansion of primary care diagnostic capabilities, increased use of over-the-counter diagnostic products, and improved accessibility of rapid tests.

The primary care poc diagnostics market is projected to experience substantial expansion in the coming years. It is anticipated to reach $24.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period can be primarily attributed to factors such as the increasing demand for decentralized diagnostic solutions, the rising incorporation of AI-enabled diagnostics, the broadening of telehealth-supported testing services, a heightened emphasis on preventive health screening, and increased investments in personalized diagnostic approaches. Key trends observed within this forecast period include the expanding adoption of rapid diagnostic testing, the growing integration of digital point-of-care devices, an escalating demand for at-home diagnostic kits, the expansion of multiplex testing platforms, and a strengthened focus on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

What Drivers Are Affecting Demand In The Primary Care POC Diagnostics Market?

The primary care POC diagnostics market is expected to see growth propelled by the increasing prevalence of infectious diseases. These conditions stem from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. They spread directly or indirectly between individuals through contact with contaminated surfaces, air, water, or vectors like insects. Contributing factors to their widespread nature include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics are crucial tools in diverse healthcare settings, combating these diseases by enabling early detection, timely treatment, and effective control measures. For instance, in March 2025, the Centers for Disease Control and Prevention (CDC), a US federal agency, reported that tuberculosis cases escalated from 9,622 in 2023 to 10,347 in 2024, an 8% increase, with the incidence rate also climbing from 2.9 to 3.0 per 100,000 population, a 6% rise. Hence, the rising prevalence of infectious diseases is a significant driver for the primary care POC diagnostics market.

Which Segments Are Gaining Traction In The Primary Care POC Diagnostics Market?

The primary care poc diagnostics market covered in this report is segmented –

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products

2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

Which Trends Are Guiding The Evolution Of The Primary Care POC Diagnostics Market?

Major companies operating in the primary care POC diagnostics market are focusing on developing advanced microfluidic-based rapid susceptibility testing to enhance timely antibiotic decision-making. Such microfluidic rapid susceptibility testing employs tiny fluid channels to swiftly isolate and cultivate bacteria, enabling early identification of their responsiveness to different antimicrobials and reducing the waiting period for results. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostic solutions company, launched the PA-100 AST System, which features proprietary microfluidic technology. This system can detect bacteria from urine samples in about 15 minutes and provide antimicrobial susceptibility test (AST) results in as little as 30 minutes at the initial clinic visit. The analyzer is compact, desktop-sized, and utilizes reagent cartridges into which samples are directly placed for automatic measurement. Healthcare professionals lacking specialized lab training can operate it easily. By accelerating diagnostics, the device supports appropriate antimicrobial use during first patient visits and assists in the global fight against antimicrobial resistance.

Who Are The Primary Competitors In The Global Primary Care POC Diagnostics Market?

Major companies operating in the primary care poc diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care poc diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Primary Care POC Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2026, By The Business Research Company

Poc Medical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/poc-medical-imaging-global-market-report

Point Of Care Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Primary Care POC Diagnostics Market Today And What Is Its Future Size?

The market size for primary care point-of-care diagnostics has seen significant growth in recent times. The market is projected to increase from $16.35 billion in 2024 to $17.38 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.3%. This growth during the historical period can be credited to the rise in chronic disease cases, the shift towards individualized medicine, growing healthcare spending, the burgeoning of supportive regulatory infrastructures and streamlined approval processes, and a heightened focus on early disease detection and preventive approaches.

In the next few years, significant expansion is expected in the primary care poc diagnostics market, with a projected size of $22.88 billion by 2029, grown at a compound annual growth rate of 7.1%. This potential growth during the forecasted period can be associated with various factors such as the rise of infectious disease outbreaks, broadening applications in non-communicable diseases, growing acceptance in home healthcare environments, expansion in precision medicine initiatives, an increase in healthcare infrastructure investments, a growing disease burden, and the escalating awareness regarding early disease diagnosis. Some major trends anticipated within this period include the fusion of artificial intelligence (AI) and machine learning algorithms, advances in molecular diagnostics technologies, the downsizing and mobility of POC diagnostic devices, the incorporation of intelligent devices, and the application of multiplexing and panel testing in POC diagnostics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

What External And Internal Drivers Are Influencing The Primary Care POC Diagnostics Market?

The escalating occurrence of infectious diseases is predicted to drive the expansion of the primary care POC diagnostics market. These are maladies triggered by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly through contact with surfaces, air, water, or vectors like insects that are contaminated. The rise in infectious diseases can be attributed to substandard environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics play a critical role in combating these diseases by enabling quick detection, prompt treatment, and effective control measures in diverse healthcare environments. For example, in October 2023, a report by the UK Health Security Agency, a UK governmental body handling public health security, stated that HIV diagnoses in England increased by 22%, moving from 3,118 in 2021 to 3,805 in 2022. Furthermore, in November 2023, the World Health Organization (WHO), a UN agency based in Switzerland focusing on global public health, highlighted that approximately 10.6 million instances of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the escalating occurrence of infectious diseases is propelling the growth of the primary care POC diagnostics market.

How Is The Primary Care POC Diagnostics Market Categorized Across Applications And Types?

The primary care poc diagnosticsmarket covered in this report is segmented –

1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products

2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices

Which Emerging Trends Are Reshaping The Primary Care POC Diagnostics Market Landscape?

In order to maximize market revenue, major corporations in the primary care POC diagnostics market are placing their focus on highly advanced technological solutions such as portable point-of-care RT-PCR systems. These portable POC RT-PCR solutions are compact, mobile devices intended to carry out real-time reverse transcription polymerase chain reaction tests outside of the traditional lab environments. For instance, an Indian molecular diagnostic solutions producer, Genes2Me Pvt. Ltd., presented the Rapi-Q Point of Care RT PCR solution for diseases such as HPV and tuberculosis in October 2022. The eight-well block system, known for its user-friendly interface, is capable of providing quicker results in under 45 minutes. The portability and featherweight of the Rapi-Q system makes it a perfect fit for set-ups like hospitals, health clinics, blood banks, research labs, and airports. The Rapi-Q system also shines in terms of sensitivity, accuracy, and performance and can synchronize with over 50 lyophilized, room-temperature disease detection kits for detecting varied diseases.

Who Are The Global Leaders Steering The Primary Care POC Diagnostics Market Forward?

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Are The Emerging Regional Trends Driving The Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2025, By The Business Research Company

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Primary Care POC Diagnostics Market Between 2025 And 2029?

The primary care point-of-care diagnostics market size has experienced considerable growth recently. It is projected to increase from $16.35 billion in 2024 to $17.38 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%. This expansion in the past can be attributed to the rising incidence of chronic diseases, the transition towards personalized medicine, increasing expenditure on healthcare, the emergence of supportive regulatory frameworks along with faster approval processes, and an elevated focus on early disease identification and prevention methods.

The primary care poc diagnostics market size is anticipated to experience substantial expansion in the coming years. By 2029, its value is projected to reach $22.88 billion, demonstrating a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is propelled by factors such as the rise of infectious disease outbreaks, broader applications in non-communicable diseases, increased utilization in home healthcare environments, advancements in precision medicine, greater investments in healthcare infrastructure, an escalating disease burden, and heightened recognition of the significance of early disease detection. Key developments expected in the forecast period encompass the incorporation of artificial intelligence (AI) and machine learning algorithms, enhancements in molecular diagnostics technologies, the shrinking size and increased mobility of POC diagnostic devices, integration with smart devices, and the application of multiplexing and panel testing within POC diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

Which Factors And Drivers Are Influencing The Primary Care POC Diagnostics Market In 2025?

An increase in the occurrence of infectious diseases is anticipated to boost the expansion of the primary care POC diagnostics market in the future. These conditions are illnesses resulting from disease-causing microorganisms like bacteria, viruses, fungi, or parasites. Such diseases transmit between individuals, either directly or indirectly, via exposure to tainted surfaces, air, water, or carriers like insects. The widespread presence of infectious diseases stems from substandard environmental circumstances, increasing urbanization, resistance to antimicrobials, and insufficient vaccination rates. Primary care POC diagnostics serve as crucial instruments in combating the widespread nature of infectious diseases, enabling prompt detection, rapid treatment, and efficient disease management strategies across various healthcare environments. For example, in October 2023, a report issued by the UK Health Security Agency, a UK-based governmental body charged with supervising and managing public health security, indicated that HIV diagnoses in England saw a 22% increase, climbing from 3,118 in 2021 to 3,805 in 2022. Moreover, in November 2023, the World Health Organization (WHO), a Switzerland-based specialized UN agency overseeing international public health, reported approximately 10.6 million global tuberculosis (TB) cases in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the growing occurrence of infectious diseases is a key factor propelling the primary care POC diagnostics market.

What Are The Different Segment Classifications Within The Primary Care POC Diagnostics Market?

The primary care poc diagnosticsmarket covered in this report is segmented –

1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products

2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices

Which Market Trends Are Creating New Opportunities In The Primary Care POC Diagnostics Industry?

Leading companies in the primary care POC diagnostics market are focusing on advanced technological solutions, including portable point-of-care RT-PCR options, to enhance their market revenue. Portable point-of-care (POC) RT-PCR solutions are compact, mobile devices engineered to perform real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside of traditional laboratory settings. For example, in October 2022, Genes2Me Pvt. Ltd., an India-based manufacturer of molecular diagnostic solutions, launched the Rapi-Q Point of Care RT PCR solution designed for conditions such as HPV and tuberculosis. This solution features an eight-well block design with four fluorescent channels, is described as user-friendly, and can deliver faster results in less than 45 minutes. The Rapi-Q system is portable and lightweight, making it suitable for use in hospitals, blood banks, health clinics, research laboratories, and airports. The solution offers high sensitivity, accuracy, and performance in detecting a variety of diseases and is compatible with over 50 lyophilized, room-temperature disease detection kits.

Which Major Firms Are Strengthening Their Position In The Primary Care POC Diagnostics Industry?

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

How Is Primary Care POC Diagnostics Market Demand Varying Across Different Regions?

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Primary Care POC Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2025, By The Business Research Company

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Primary Care POC Diagnostics Market From 2025 To 2029?

In past years, there has been a notable expansion in the primary care point-of-care (poc) diagnostics market. It is projected to surge from $16.35 billion in 2024 to $17.38 billion in 2025, with the compound annual growth rate (CAGR) estimated at 6.3%. Factors contributing to this growth during the historic period include the rising incidence of chronic illnesses, the movement towards personalized healthcare, increased healthcare spending, supportive regulatory structures and faster approval procedures, as well as an increased focus on early detection and preventive measures for diseases.

The market for primary care POC diagnostics is projected to witness robust expansion in the coming years, with expectations to climb to$22.88 billion in 2029 at a CAGR of 7.1%. Factors contributing to the growth within the forecast period includes the occurrence of infectious disease outbreaks, broadening applications in non-communicable disease sectors, escalating acceptance in home healthcare systems, progress in precision medicine initiatives, increase in healthcare infrastructural investments, amplified disease burden, and rising consciousness about the critical role of disease detection in its early stages. Key trends in the forecast period encompass the application of artificial intelligence (AI) and machine learning algorithms, developments in molecular diagnostics technologies, miniaturization and increased portability of POC diagnostic instruments, integration with smart devices, and the increasing employment of multiplexing and panel testing within POC diagnostics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

What Are the Core Growth Drivers Propelling the Primary Care POC Diagnostics Market Forward?

The increasing occurrence of infectious diseases is anticipated to spur the growth of the primary care POC diagnostics market in the future. Infectious diseases, which are caused by disease-causing microorganisms such as bacteria, viruses, fungi, or parasites, can spread from one person to another directly or indirectly through various contact mediums such as contaminated surfaces, air, water, or through vectors like insects. The rising incidence of infectious diseases can be attributed to factors like unfavorable environmental conditions, urbanization, resistance to antimicrobial drugs, and inadequate immunization coverage. Primary care POC diagnostics play a crucial role in fighting against infectious diseases as it allows for early detection, prompt treatment, and effective disease containment strategies in various healthcare settings. For instance, a report in October 2023 by the UK Health Security Agency, a UK-based government body responsible for managing public health security, revealed that the number of HIV diagnoses in England saw a 22% rise from 3,118 in 2021 to 3,805 in 2022. In addition, in November 2023, the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for global public health, stated that approximately 10.6 million cases of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Hence, the increasing prevalence of infectious diseases is fostering the growth of the primary care POC diagnostics market.

What Segment Types Define the Primary Care POC Diagnostics Market Structure?

The primary care poc diagnosticsmarket covered in this report is segmented –

1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products

2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Primary Care POC Diagnostics Market?

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing thePrimary Care POC Diagnostics Industry Evolution?

Leading enterprises involved in the primary care POC diagnostics arena are concentrating on incorporating advanced technology solutions like portable point-of-care RT-PCR instruments to escalate their market revenue. These portable POC RT-PCR devices are small, easy-to-move gadgets engineered to carry out real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside conventional lab environments. For example, Genes2Me Pvt. Ltd., a molecular diagnostic solutions firm based in India, introduced its Rapi-Q Point of Care RT PCR system geared towards diseases like HPV and tuberculosis in October 2022. The system is promoted as simple to operate, presenting quicker outcomes in under 45 minutes, and has an eight-well layout with four fluorescent channels. The portable and lightweight nature of the Rapi-Q system renders it appropriate for venues such as hospitals, blood banks, health clinics, research labs, and airports. The device delivers excellent sensitivity, precision, and efficacy in identifying a range of illnesses and is adaptable with over 50 lyophilized, room-temperature disease detection kits.

View the full report here:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Is the Definition of the Primary Care POC Diagnostics Market?

A primary care point-of-care (POC) diagnostic is a medical test or assessment performed conveniently and quickly within a primary care setting, such as a doctor’s office or a clinic, without requiring specialized equipment or extensive laboratory processing. These diagnostics are designed to provide rapid results, allowing healthcare providers to make timely decisions about patient care during the initial consultation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15642

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of thePrimary Care POC Diagnostics Market from 2025 to 2034?

The rise in the prevalence of infectious diseases is expected to drive the growth of the primary care POC diagnostics market. Infectious diseases spread through contact with contaminated surfaces, air, or vectors. Factors such as poor environmental conditions, urbanization, antimicrobial resistance, and inadequate vaccination coverage contribute to their prevalence. Primary care POC diagnostics aid early detection and treatment. For instance, a report from the UK Health Security Agency in October 2023 showed a 22% rise in HIV diagnoses in England from 2021 to 2022. Additionally, the WHO reported in November 2023 that global tuberculosis cases rose to 10.6 million in 2022. Hence, the rise in infectious diseases is propelling the primary care POC diagnostics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

#What Growth Opportunities Will Drive the Primary Care POC Diagnostics Market’s CAGR Through 2034?

The primary care POC diagnostics market size has experienced strong growth, projected to grow from $16.46 billion in 2024 to $17.78 billion in 2025 at a CAGR of 8.0%. This growth is driven by factors such as the increasing prevalence of chronic diseases, a shift toward personalized medicine, growing healthcare spending, supportive regulatory frameworks, expedited approval processes, and a focus on early disease detection and prevention strategies.

The primary care POC diagnostics market is expected to reach $23.86 billion by 2029, growing at a CAGR of 7.6%. The growth can be attributed to infectious disease outbreaks, the rise of non-communicable diseases, home healthcare, precision medicine, healthcare investments, increasing disease burden, and early detection awareness. Trends include AI integration, molecular diagnostic advancements, portable devices, and multiplexing in diagnostics.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15642

How Are Market Trends and Innovations Revolutionizing thePrimary Care POC Diagnostics Industry in Recent Times?

Companies in the primary care POC diagnostics market are focusing on portable point-of-care RT-PCR solutions. In October 2022, Genes2Me Pvt. Ltd. from India launched the Rapi-Q Point of Care RT-PCR solution, a portable and fast diagnostic tool designed for diseases like HPV and tuberculosis, offering high sensitivity and accuracy in detecting various conditions.

Which Key Market Players Are Shaping the Future and Growth of thePrimary Care POC Diagnostics Market?

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Are the Core Segments of the Primary Care POC Diagnostics Market, and How Do They Contribute to Growth?

The primary care POC diagnostics market covered in this report is segmented –

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products

2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing

3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:

1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions

2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices

3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests

4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors

5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices

6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits

7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices

8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices

9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests

10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

What Regions Are Dominating the Primary Care POC Diagnostics Market Growth?

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2025, By The Business Research Company:

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Breast Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: